Medtronic (NYSE: MDT) today announced the first results from the high cardiovascular risk cohort of its SPYRAL AFFIRM study.
The medical-device giant is positioning its Hugo RAS system to compete with Intuitive Surgical's da Vinci systems.
Techsomed Ltd., an Israel-based developer of medical artificial intelligence–powered software for image-guided therapy, a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback